OPK

1.5702.48%
JH

Jane H. Hsiao

Vice Chairman of the Board & Chief Technical Officer

Dr. Jane H. Hsiao, Ph.D., MBA, has been an Interim Chief Executive Officer of Non-Invasive Monitoring Systems Inc. since February 28, 2012 and has been its Chairman since October 2008 and its Director since October 2008. Dr. Hsiao has been the Vice Chairman of the Board and Chief Technical Officer of Opko Health, Inc. since May 2007 and has been its Director since February 2007. She serves as Investment Officer at Frost Group, LLC. She was the Founder at Innotech Laboratory in 1981 and IVAX LLC in 1986. She served as the President of Ophthalmic Technologies, Inc. Dr. Hsiao served as the Vice Chairman-Technical Affairs and Chief Technical Officer of IVAX, from 1995 until January 2006. She serves as a Director of Acuity Pharmaceuticals Inc., Fabrus, Inc., Cocrystal Discovery, Inc. and Froptix Corporation. She has been the Chairman of; and Cellular Technical Services Co. Inc. since September 05, 2007. She served as the Chairman of SafeStitch Medical, Inc. since September 05, 2007. She is Chairman, Chief Executive Officer, President of DVM Pharmaceuticals Inc. and Director of IVAX Diagnostics Inc at IVAX LLC. She has been a Director of Protalix Ltd. since August 2006; OPKO Biologics since May 2007 and Cellular Technical Services Company, Inc. since September 5, 2007. She served as the Chief Executive Officer and President of IVAX Animal Health, IVAX’ veterinary products subsidiary of IVAX LLC from March 1998 to 2006. Dr. Hsiao also served as Chairman, CEO and President of IVX Animal Health from 1998 until 2006. From 1992 to February 1995, she served as IVAX LLC‘s Chief Regulatory Officer and Assistant to the Chairman and Vice President of Quality Assurance and Compliance of IVAX Research, Inc. From 1987 to 1992, she served as a Vice President of Quality Assurance, Quality Control and Regulatory Affairs at IVAX Research, Inc. She served as the Chairman of DVM Pharmaceuticals Inc. from March 1998 to 2006. She served as a Vice Chairman of IVX Animal Health. She served as a Vice Chairman-Technical Affairs and Director of IVAX LLC from 1995 to January 2006, when Teva acquired IVAX. Dr. Hsiao had been Independent Director of Cocrystal Pharma, Inc. since January 2, 2014 until April 15, 2020. She had been a Director of Asensus Surgical, Inc. (formerly, TransEnterix, Inc.) since 2005 until June 13, 2022. She served as a Director of Medical Ventures Corp. and its Independent Director since July 1, 2008. She served as a Director of SafeStitch Medical, Inc. since April 2005. She served as a Director of Protalix Biotherapeutics Ltd. from December 31, 2006 to December 2007; IVAX Pharmaceuticals s.r.o. (Ivax-CR AS); eXegenics Inc. since February 9, 2007; Orthodontix Inc., since January 3, 2007; IVAX Corp. since 1995 and IVAX Diagnostics Inc., from 2001 to April 2006. She was a Director of Tissuetech, Inc. She served as Director of Prolor & Sorrento Therapeutics, Inc. since January 2010. Dr. Hsiao has background in building and growing companies in the pharmaceutical and medical device industry and has strong technical expertise, as well as her senior management experience and extensive Board service. Her broad experience in many biotechnology and life science companies gives her a keen understanding and appreciation of the many regulatory and developmental issues confronting medical device, pharmaceutical and biotechnology companies. Additionally, Dr. Hsiao served as a Director to Neovasc, Inc. since July l, 2008 until September 16, 2019. Dr. Hsiao received a B.S. degree in Pharmacy from the National Taiwan University and a Ph.D. degree in Pharmaceutical Chemistry and Medicinal Chemistry from the University of Illinois, Chicago in 1973. She also holds an M.B.A. degree.

Positions